194 related articles for article (PubMed ID: 11266948)
1. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts.
Chueh SC; Chen JR; Chen J; Lai MK
Transplant Proc; 2001; 33(1-2):542-3. PubMed ID: 11266948
[No Abstract] [Full Text] [Related]
2. Rescuing acute rejection of rat cardiac allografts with FTY720.
Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
[No Abstract] [Full Text] [Related]
3. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation.
Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P
Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447
[No Abstract] [Full Text] [Related]
4. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
Yuzawa K; Stephkowski SM; Wang M; Kahan BD
Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
[No Abstract] [Full Text] [Related]
5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
6. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy.
Koshiba T; Van Damme B; Lu Y; Yan Y; Rutgeerts O; Overbergh L; Tanaka K; Waer M; Mathieu C; Pirenne J
Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170
[No Abstract] [Full Text] [Related]
7. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
Xu M; Antoniou EA; Afford SC; Suzuki S; Pirenne J; McMaster P; D'Silva M
Transplant Proc; 1997 Nov; 29(7):2964-6. PubMed ID: 9365631
[No Abstract] [Full Text] [Related]
8. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
[No Abstract] [Full Text] [Related]
9. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
[No Abstract] [Full Text] [Related]
11. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
Matsumoto Y; Hof RP
Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
[No Abstract] [Full Text] [Related]
12. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
[No Abstract] [Full Text] [Related]
13. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.
Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420
[No Abstract] [Full Text] [Related]
14. CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas.
Kita Y; Li XK; Nogimura H; Ida M; Kageyama Y; Ohi S; Suzuki K; Kazui T; Suzuki S
Transplant Proc; 2003 Feb; 35(1):458-60. PubMed ID: 12591486
[No Abstract] [Full Text] [Related]
15. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.
Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S
Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526
[No Abstract] [Full Text] [Related]
16. Effect of a new immunosuppressant, FTY720, on joint allografts.
Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y
J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
[No Abstract] [Full Text] [Related]
18. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Nikolova Z; Hof A; Baumlin Y; Hof RP
Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
[TBL] [Abstract][Full Text] [Related]
19. An effect of FTY720 on acute rejection in canine renal transplantation.
Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
[No Abstract] [Full Text] [Related]
20. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation.
Mitsusada M; Suzuki S; Kobayashi E; Enosawa S; Kakefuda T; Miyata M
Transpl Int; 1997; 10(5):343-9. PubMed ID: 9287398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
